Cardiovascular and Cerebrovascular Implications of Growth Restriction: Mechanisms and Potential Treatments

Charmaine R Rock1,2, Tegan A White1,2, Beth R Piscopo1,2

  • 1The Ritchie Centre, Hudson Institute of Medical Research, Clayton 3168, Australia.

Insights

Fetal growth restriction (FGF) due to chronic hypoxia impacts fetal brain development. Brain sparing redirects blood flow, but long-term effects like cerebral palsy and ADHD may emerge in affected offspring.

Area of Science:

  • Obstetrics and Gynecology
  • Fetal Medicine
  • Neuroscience

Background:

  • Fetal growth restriction (FGR) is a pregnancy complication where the fetus doesn't reach its growth potential.
  • FGR typically results from reduced oxygen and nutrient supply, leading to chronic hypoxia.
  • The fetal response to chronic hypoxia, unlike acute hypoxia, is not well understood.

Purpose of the Study:

  • To review the impact of brain sparing on fetal cardiovascular and cerebrovascular systems in FGR.
  • To explore the pathogenesis of brain sparing within the cerebrovascular system.
  • To highlight emerging long-term effects in offspring born with FGR.

Main Methods:

  • Literature review focusing on fetal adaptation to chronic hypoxia.
  • Analysis of cardiovascular and cerebrovascular responses in FGR.
  • Exploration of neuropathological outcomes linked to FGR and brain sparing.

Main Results:

  • Fetal adaptation to chronic hypoxia involves cardiac output redistribution, known as brain sparing.
  • Brain sparing aims to preserve function in the developing brain despite reduced supply.
  • Emerging evidence links FGR and brain sparing to long-term neurodevelopmental issues.

Conclusions:

  • Understanding brain sparing mechanisms is crucial for preventing adverse neurodevelopmental outcomes in FGR offspring.
  • Further research is needed to elucidate pathways leading to conditions like cerebral palsy, autism, and ADHD.
  • Targeting these pathways could mitigate long-term neurological deficits in growth-restricted infants.

Related Concept Videos

Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
129
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.5K
Regulation of the Cardiovascular System01:27

Regulation of the Cardiovascular System

The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
2.5K
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
2.1K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
542